First Time Loading...

Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 67.01 USD -0.95% Market Closed
Updated: May 16, 2024

Gilead Sciences Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gilead Sciences Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
AMGN
MRNA
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$757m
CAGR 3-Years
35%
CAGR 5-Years
0%
CAGR 10-Years
-10%
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
8%
CAGR 5-Years
-7%
CAGR 10-Years
-19%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.9B
CAGR 3-Years
-44%
CAGR 5-Years
-30%
CAGR 10-Years
-16%
Moderna Inc
NASDAQ:MRNA
Interest Income Expense
$345m
CAGR 3-Years
219%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$563.1m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$221.8m
CAGR 3-Years
-13%
CAGR 5-Years
75%
CAGR 10-Years
N/A

See Also

What is Gilead Sciences Inc's Interest Income Expense?
Interest Income Expense
-757m USD

Based on the financial report for Mar 31, 2024, Gilead Sciences Inc's Interest Income Expense amounts to -757m USD.

What is Gilead Sciences Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-10%

Over the last year, the Interest Income Expense growth was 57%. The average annual Interest Income Expense growth rates for Gilead Sciences Inc have been 35% over the past three years , and -10% over the past ten years .